Search

Showing "11155" results for ""

Severe interaction between low-dose ritonavir and a blood pressure drug observed

Malaria treatment compromised by suppressed immunity in HIV-positive adults

Gilead grants royalty-free licenses for tenofovir use in microbicides

Hormonal contraception does not increase HIV infection risk

Why did HIV therapy have some benefits for a man with resistance to nearly every antiretroviral?

Two circumcision studies halted after circumcised men's HIV risk halved

Siblings of HIV/HCV coinfected patients also have higher mortality risk

HIV-positive women often infected with multiple HPV subtypes

Prezista (darunavir) approved for treatment-experienced patients in Europe

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests

HIV vaccine trials: measurements may overestimate participant understanding

Atazanavir: genetic predictors for hyperbilirubinemia found

Is HIV causing cardiovascular disease by its own effects on cholesterol?

Triple nuke combination of AZT/3TC/tenofovir below current standards as a first-line regimen

GSK halts development of new PI, brecanavir

10% of new TB cases involve drug resistance

Most HIV-positive patients do as well as HIV-negative counterparts following surgery

CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences

Receive the latest HIV research and conference news

Showing "11155" results for ""

Severe interaction between low-dose ritonavir and a blood pressure drug observed

Malaria treatment compromised by suppressed immunity in HIV-positive adults

Gilead grants royalty-free licenses for tenofovir use in microbicides

Hormonal contraception does not increase HIV infection risk

Why did HIV therapy have some benefits for a man with resistance to nearly every antiretroviral?

Two circumcision studies halted after circumcised men's HIV risk halved

Siblings of HIV/HCV coinfected patients also have higher mortality risk

HIV-positive women often infected with multiple HPV subtypes

Prezista (darunavir) approved for treatment-experienced patients in Europe

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests

HIV vaccine trials: measurements may overestimate participant understanding

Atazanavir: genetic predictors for hyperbilirubinemia found

Is HIV causing cardiovascular disease by its own effects on cholesterol?

Triple nuke combination of AZT/3TC/tenofovir below current standards as a first-line regimen

GSK halts development of new PI, brecanavir

10% of new TB cases involve drug resistance

Most HIV-positive patients do as well as HIV-negative counterparts following surgery

CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences

Receive the latest HIV research and conference news